Credit Suisse Ag Axogen, Inc. Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$4.68 - $9.26 $7,305 - $14,454	-1,561 Reduced 3.04%	49,780 $248,000
Q2 2023 Aug 11, 2023	BUY	$8.5 - $10.38 $180,013 - $219,827	21,178 Added 70.21%	51,341 $468,000
Q1 2023 May 10, 2023	BUY	$7.53 - $10.95 $75 - $109	10 Added 0.03%	30,163 $285,000
Q4 2022 Feb 13, 2023	BUY	$9.44 - $13.09 $282,501 - $391,731	29,926 Added 13183.26%	30,153 $300,000
Q3 2022 Nov 10, 2022	BUY	$8.14 - $12.25 $1,847 - $2,780	227 New	227 $3,000
Q2 2022 Aug 12, 2022	SELL	$6.99 - $10.0 $264,851 - $378,900	-37,890 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$7.26 - $10.7 $15,623 - $23,026	2,152 Added 6.02%	37,890 $301,000
Q4 2021 Feb 14, 2022	SELL	$8.8 - $16.0 $24,648 - $44,816	-2,801 Reduced 7.27%	35,738 $335,000
Q3 2021 Nov 12, 2021	BUY	$15.23 - $21.72 $42,506 - $60,620	2,791 Added 7.81%	38,539 $609,000
Q2 2021 Aug 16, 2021	BUY	$17.8 - $23.5 $166,625 - $219,983	9,361 Added 35.48%	35,748 $772,000
Q1 2021 May 14, 2021	SELL	$17.18 - $22.6 $351,468 - $462,350	-20,458 Reduced 43.67%	26,387 $534,000
Q4 2020 Feb 12, 2021	BUY	$11.5 - $17.96 $201,261 - $314,317	17,501 Added 59.64%	46,845 $840,000
Q3 2020 Nov 13, 2020	SELL	$10.62 - $13.12 $59,217 - $73,157	-5,576 Reduced 15.97%	29,344 $341,000
Q2 2020 Aug 12, 2020	BUY	$7.35 - $10.81 $80,489 - $118,380	10,951 Added 45.69%	34,920 $323,000
Q1 2020 May 13, 2020	BUY	$8.38 - $17.34 $1,860 - $3,849	222 Added 0.93%	23,969 $250,000
Q4 2019 Feb 12, 2020	SELL	$11.18 - $18.6 $24,316 - $40,455	-2,175 Reduced 8.39%	23,747 $425,000
Q3 2019 Nov 12, 2019	SELL	$12.09 - $20.46 $69,457 - $117,542	-5,745 Reduced 18.14%	25,922 $322,000
Q2 2019 Aug 14, 2019	BUY	$18.5 - $25.47 $19,388 - $26,692	1,048 Added 3.42%	31,667 $626,000
Q1 2019 May 14, 2019	BUY	$14.62 - $22.13 $33,757 - $51,098	2,309 Added 8.16%	30,619 $644,000
Q4 2018 Feb 13, 2019	SELL	$17.09 - $38.25 $799,880 - $1.79 Million	-46,804 Reduced 62.31%	28,310 $579,000
Q3 2018 Nov 13, 2018	SELL	$34.05 - $55.9 $184,380 - $302,698	-5,415 Reduced 6.72%	75,114 $2.77 Million
Q2 2018 Aug 14, 2018	BUY	$36.15 - $52.5 $295,309 - $428,872	8,169 Added 11.29%	80,529 $4.05 Million
Q1 2018 May 15, 2018	BUY	$24.4 - $40.25 $902,995 - $1.49 Million	37,008 Added 104.68%	72,360 $2.64 Million
Q4 2017 Feb 14, 2018	BUY	$18.5 - $28.6 $108,965 - $168,454	5,890 Added 19.99%	35,352 $1 Million
Q3 2017 Nov 14, 2017	BUY	$14.65 - $19.35 $431,618 - $570,089	29,462	29,462 $570,000

Others Institutions Holding AXGN

# of Institutions

163

Shares Held

36.6M

Call Options Held

230K

Put Options Held

400

First Light Asset Management, LLC Edina, MN

4.09M
Shares

$73.8 Million
5.0% of portfolio
Black Rock Inc. New York, NY

3.25M
Shares

$58.7 Million
0.0% of portfolio
Soleus Capital Management, L.P. Greenwich, CT

3.01M
Shares

$54.3 Million
3.58% of portfolio
Morgan Stanley New York, NY

2.9M
Shares

$52.4 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

2.43M
Shares

$43.8 Million
0.0% of portfolio

View Full List

About Axogen, Inc.

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $763M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

More about AXGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account